Lantheus Shares Down Nearly 9% On News Of Evergreen Theragnostics Acquisition

(RTTNews) - Lantheus Holdings, Inc. (LNTH), a radiopharmaceutical company, experienced a 9% drop in its stock price on Tuesday after announcing a deal to acquire Evergreen Theragnostics, Inc.

Currently, trading at $90.03, the stock is down $8.28, marking an 8.42 percent decline on the Nasdaq.

Lantheus opened today at $99.91 after closing the previous day at $98.31. During the trading session, the stock has fluctuated between $89.85 and $100.99. Over the past 52 weeks, the stock has ranged from $51.79 to $126.89.

The acquisition, structured as an all-cash transaction, includes an upfront payment of $250 million and up to $752.5 million in potential milestone payments. While this move could strategically enhance Lantheus' product portfolio, the financial implications of such a sizable deal appear to have raised concerns among investors.